TTrialPathMatch Me to Trials
← Back to trials
RecruitingCognitive ImpairmentSleep Quality

Benefits of Nicotinamide Riboside Upon Cognition and Sleep

Eligible age

65–85 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Poor sleep quality and short sleep duration may be a mechanistic component of cognitive impairment in older adults, associated with a decline in brain-derived neurotrophic factor. Increasing the availability of nicotinamide adenine dinucleotide (NAD+) with supplementation of its precursor, nicotinamide riboside (NR), a form of vitamin B3 may increase the expression of brain-derived neurotrophic factor. This study proposes to examine the benefits of NR supplementation on sleep and cognitive function in older adults with comprehensive subjective and objective measures and to explore its impacts on serum brain-derived neurotrophic factor.

Sponsor: State University of New York at Buffalo

You may qualify if…

  • Sleep Quality. Pittsburgh Sleep Quality Index (PSQI) global score \>5

You may not qualify if…

  • Dementia. Veteran Affairs - St. Louis University Mental Status questionnaire (VA-SLUMS) score \<20

Where it's recruiting

New York

Buffalo

Source: ClinicalTrials.gov · NCT05500170 · last updated 2025-08-22